gms | German Medical Science

30. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie

09.11. - 10.11.2023, Köln


Meeting Abstract (23gaa01)

Pharmacological and non-pharmacological treatment of sleep disorders in the hospital

Aldudak Tursun C, Thürmann P, Schmiedl S
Meeting Abstract (23gaa02)

Scientific application of the web-based health portal VITERIO for the acquisition and analysis of digital outcome parameters

Bachmeier B, Melchart D
Meeting Abstract (23gaa03)

Synthesizing evidence-based recommendations for tapering psychotropic, sedative, and anticholinergic medications: A rapid review

Bernartz K, Claaßen S, Chapidi K, Chapidi P, Picker-Huchzermeyer S, Nolte H, Dreischulte T, Härdtlein A, Brisnik V, Mortsiefer A, Peter S, Maas M, Seidling H, Klasing S, Horowitz M, Muth C, Puzhko S
Meeting Abstract (23gaa04)

Controversy from pharmacovigilance of acetylsalicylic acid as a suspect causative agent for appearance and disappearance of Reye’ Syndrome in children

Bernd A, Möser EM, Vogel D, Wofram K, Ivonchyk O, Heuer H
Meeting Abstract (23gaa05)

Safety first? Drug-related problems at admission to surgery: A retrospective study

Clemens S, Simon C, Kanduth K, Rose O
Meeting Abstract (23gaa06)

Real-world evidence on the use of herbal medicines in gynecological complaints

Drebka A, Ochs T, Raskopf E, Shah-Hosseini K, Mösgens R, Bachmeier B
Meeting Abstract (23gaa07)

Analysis of adverse drug reaction reports related to fluoroquinolones between 2014–2019 and 2020–2022

Dubrall D, Wicherski J, Schmid M, Haenisch B, Sachs B
Meeting Abstract (23gaa08)

Results and experiences of the ARMIN model project (“Arzneimittelinitiative Sachsen-Thueringen”)

Fuchs A
Meeting Abstract (23gaa09)

Results and learnings of the project to improve the transparency of medicaction process in nursing homes (“Arzneimitteltransparenz im Pflegeheim”)

Fuchs A
Meeting Abstract (23gaa10)

Do privately insured patients receive new antidiabetic drugs earlier than patients insured under the statutory health insurance scheme? The case of glucagon-like peptide 1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors

Grimmsmann T, Kostev K, Himmel W
Meeting Abstract (23gaa11)

Differences in psychopharmacological outpatient treatment between suicidal adolescents suffering from adjustment disorders and major depressive disorders

Hach I, Bertsch T, Nonell P
Meeting Abstract (23gaa12)

A geriatric pharmacist’s contribution to nurses’ education on medication – medication in care planning

Hagedorn M
Meeting Abstract (23gaa13)

Antibiotic use in patients with urinary tract infections: Prescription trends from 2015 to 2019

Jobski K, Schmiemann G, Hamprecht A, Hoffmann F
Meeting Abstract (23gaa14)

Introduction of a unit-dose supply in the context of closed-loop medication management at a clinic of the University Hospital Jena (UKJ) – acceptance and feasibility from the ward staff point of view

Kessler C, Meissner F, Iffland A, Hartmann M, Bleidorn J, Farker K
Meeting Abstract (23gaa15)

Pain therapy in patients without a diagnosis of malignant neoplasm: Frequency of non-opioids and opioids prescribing and observed drug therapy safety risks

Lappe V, Schubert I, Grandt D
Meeting Abstract (23gaa16)

Multiple sclerosis: Detecting adverse effects with routine practice data

Marx C, Basoglu A, Berger K, Drechsel-Bäuerle U, Keller-Stanislawski B, Kexel E, Kraft K, Stahmann A, Below M
Meeting Abstract (23gaa17)

Assessing the relevance of drug-related problems and pharmaceutical interventions in the interprofessional medication management programme ARMIN

Müller U, Eickhoff C, Petersen M, Strunz AK, Ruschkowski M, Schulz M
Meeting Abstract (23gaa18)

Development of a qualitative online survey on need, request, acceptance, benefits, and accessibility of herbal medicines for the treatment of gynaecological complaints

Ochs T, Bößneck N, Jalil B, Heinrich M, Bachmeier B
Meeting Abstract (23gaa19)

How do sex and gender influence chronic pain therapy? – Analysis of existing literature for the GESCO-Study Sex- and gender-sensitive primary care intervention for patients with chronic non-cancer pain (CNCP) receiving long-term opioid therapy (LTOT))

Preuß J, Bencheva V, Mortsiefer A, Schmidt A, Pitrowski A, Weckbecker K, Kufeld N, Just J, Wiese B, Kersting C, Thürmann P
Meeting Abstract (23gaa20)

Medical drug expertise assessments in the Quality Assurance in the Medical Advisory Service Institutions in Germany

Ries V, Schuster R, Menz PU, Burmester M
Meeting Abstract (23gaa21)

Polypharmacy in older multimorbid patients: Agreement between GP-reported and patient-reported drugs

Schäfer L, Paulitsch M, Hanf M, Dinh TS, Klein AA, Klasing S, Seidling HM, Voigt K, van den Akker M
Meeting Abstract (23gaa22)

Prevalence and time trends of potentially drug-related hospital admissions

Schechner M, Weglage C, Rottenkolber M, Dreischulte T
Meeting Abstract (23gaa23)

Prescribing of opioid analgesics in Germany: Opposite trends when different quantification measures are used

Scholle O, Jobski K, Viebrock J, Haug U
Meeting Abstract (23gaa24)

Consistency of recommendations for pharmacological treatment of predisposing conditions as an essential component of primary cardiovascular disease prevention in general practice: Findings from a systematic guideline review

Schürmann L, Bredehorst M, González-González AI, Muth C, Van der Wardt V, Haasenritter J, Puzhko S
Meeting Abstract (23gaa25)

Antibiotic prescriptions before, during and after the corona pandemic in Schleswig-Holstein

Schuster R, Emcke T, von Arnstedt E, Ries V, Burmester M
Meeting Abstract (23gaa26)

Potential life-threatening adverse drug reactions of fluoroquinolones – a pharmacoepidemiological analysis in German health claims data

Wicherski J, Peltner J, Astvatsatourov A, Becker C, Schüssel K, Brückner G, Schlotmann A, Schröder H, Kern W, Weltermann B, Haenisch B
Meeting Abstract (23gaa27)

Gender differences in drug prescribing by disease group

Zawinell A, Niepraschk-von Dollen K